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Renal lesions and proteinuria in the spontaneously hypertensive rat
made normotensive by treatment. Spontaneously hypertensive rats
(SHR) (N = 40)were maintained at normal blood pressure to the age of
100 weeks by treatment (reserpine, hydralazine, and chiorothiazide)
beginning at intervals in groups of eight, from the 5th to 45th week.
Mortality rates, patterns of proteinuria, and glomerular and arteriolar
pathology were compared with that of treated and untreated normoten-
sive Wistar-Kyoto (WKY) controls matched for age (N = 39) and
untreated SHR's (N = 26). Treatment clearly prolongs life in SHR's,
the mortality rate for untreated being 100% at 75 weeks versus no
deaths at that age among 24 SHR's treated before 20th week. At 100
weeks, treated SHR's were excreting eight times the baseline values of
urinary protein, whereas WKY's had hardly increased from baseline
values. At 100 weeks, normotensive SHR's showed fibrinoid necrosis,
sclerosis, and pericapsular fibrosis of glomeruli, whereas no morpho-
logic damage was found in glomeruli or renal arterioles of WKY.
Glomerular lesions in normotensive SHR's are indistinguishable in kind
from their hypertensive counterparts, but occur somewhat later. Juxta-
medullary glomeruli initially suffer the greatest damage and appear to be
the major source of urinary protein. These findings speak against the
hypothesis of an increased intravascular pressure as the major factor in
the pathogenesis of arteriolar sclerosis and rather favor a genetic defect
in the vascular system of the SHR, a defect strongly associated with the
hypertensive trait. A possible relationship of this defect to inherited
membrane abnormalities recently described in RBC and smooth muscle
cells of SHR is discussed.
Lesions rénales et protéinurie chez le rat spontanément hypertendu
rendu normotendu par le traitement. Des rats spontanément hypertendu
(SH) (N = 40) ont été maintenus a une pression artérielle normale
jusqu'a l'age de 100 semaines par un traitement (reserpine, hydralazine
et chlorothiazide) commencant a des temps différents pour chaque
groupe de huit rats entre Ia 5è et Ia 45è semaine. La mortalitd, les
modalités de Ia protéinurie et de Ia pathologic glomerulaire et artério-
laire ont été comparées a celles de rats contrôles Wistar-Kyoto (WKY),
apparies pour l'hge, traités ou non traités (N = 39) et de rats SHR non
traités (N = 26). Le traitement prolonge Ia durée de vie de SHR de
facon importante, Ia mortalite en l'absence de traitement étant 100% a
75 semaines par opposition a I'absence de morts au méme age parmi 24
SHR traités avant Ia 20è semaine. A 100 semaines les SHR traités
avaient une excretion urinaire de protéines égale a 8 fois Ia valeur basale
alors que les WKY n'avaient pratiquement pas augmenté leur excretion
par rapport a Ia valeur basale. A 100 semaines les SHR normotendus
avaient de La nCcrose fibrinoIde, de Ia sclérose et de Ia fibrose
péricapsulaire des glomérules alors qu'il n'a pas été observe d'anoma-
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lies morphologiques des glomerules ou des arterioles rCnales chez les
WKY. Les lesions glomerulaires des SHR normotendus ne sont pas
différentes de celles de leurs homologues hypertendus mais elles
surviennent un peu plus tard. Les glomérules juxtamedullaires subis-
sent en premier les lesions les plus importantes et semblent étre Ia
source majeure de Ia protCinurie. Ces constatations vont a l'encontre de
l'hypothèse d'une augmentation de Ia pression intravasculaire comme
facteur majeur de Ia sclérose artériolaire et sont plutôt en faveur d'un
deficit génetique du système vasculaire des SHR, deficit fortement
associé au trait hypertensif. Une relation possible de cc deficit avec les
anomalies membranaires héréditaires récemment décrites dans Ic glob-
ule rouge et les cellules musculaires lisses de SHR est discutée.
Since the classic reports of Bell and Clawson in 1928 and of
Castleman and Smithwick in 1948, it has been generally accept-
ed that the lesions of arteriolar nephrosclerosis are caused by
hypertension [1, 2]. The conclusion was reached by applying
strict clinical and anatomical criteria to a study of nearly a
thousand cases of human hypertension, from material obtained
at autopsy [1] or during surgical sympathectomy [2]. The
intervening decades have produced little substantial evidence to
challenge this opinion, and it remains paramount in contempo-
rary writing [3—5].
The spontaneously hypertensive rat (SHR), the closest model
to date of human essential hypertension, exhibits the character-
istic vascular lesions of arteriolar nephrosclerosis [6, 7]. If
hypertension were the cardinal cause of the lesions, they should
be preventable by successful control of the blood pressure.
Freis et al [8] in fact reported prevention of target-organ disease
in the SHR treated with antihypertensive agents from 12 to 36
weeks of age. Target organs of these animals and of untreated
controls were examined histologically at 52 weeks. None of the
treated animals showed the vascular lesions of hypertension [8].
Feld et al (7) described a distinctive pattern of proteinuria and
glomerular injury developing in the SHR during the 1st year of
life. Because age-matched normotensive Wistar-Kyoto controls
(WKY) exhibited neither proteinuria nor glomerular injury, that
study seemed also to support the pressure theory of the
pathogenesis of these findings in the SHR.
In the present study, we have used the therapeutic regimen of
Freis et a! [8] to maintain groups of SHR's at normal arterial
pressure from 5 to 100 weeks of age. Matched groups of WKY's
(treated and untreated) and of untreated SHR's were followed
in parallel. The evolution of proteinuria was monitored as in our
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earlier investigation, and histology of heart and kidneys was
examined terminally in all animals.
It will be shown that, despite rigorous control of blood
pressure, marked proteinuria developed in all SHR's during the
second year of treatment, and the lesions characteristic of
hypertensive nephropathy were apparent on examination by
light microscopy. Again, neither proteinuria nor lesions were
found in treated or untreated WKY controls. Those results
make necessary a reassessment of the role of arterial pressure
in the pathogenesis of arteriolar sclerosis and are discussed in
the light of recent evidence for genetic membrane deficiencies
in the SHR.
Methods
Male rats used in this study were of the Wistar-Okamoto
spontaneously hypertensive (SHR) strain (N = 66) and the
Wistar-Kyoto (WKY) normotensive strain (N = 39). All ani-
mals were obtained from Laboratory Supply Company, India-
napolis, Indiana. The SHR and WKY were F-generations 40, 41
and 17, 18, respectively. A minimum of I week was allowed for
the animals to acclimate to our facilities before any experimen-
tal procedures were performed. All animals had free access to
food and water. A reduction in the number of rats under study
occurred as animals from each of the groups were used for
micropuncture experiments. WKY values reported here are the
average of untreated and treated animals, except for blood
pressure and mortality data.
Blood pressure measurements. Indirect systolic blood pres-
sure (BP) was determined by the tail-cuff method (Narco
Biosysterns) without anesthesia, the animals soon becoming
accustomed to the procedure, The average of at least three
readings, taken in a quiescent state, was recorded.
Weights. Body weights were recorded to the nearest gram by
use of a triple beam balance (Ohaus Scale Corp., Union, New
Jersey). Heart and kidneys from each experimental animal were
immersed briefly in 10% phosphate-buffered formalin and then
weighed on a Mettler balance to the nearest tenth of a gram.
Urine volumes were equated with urine weight.
Drug therapy. Antihypertensive therapy consisted of a corn-
bination of reserpine (1.4 mg/liter; Serpasil®, Ciba) hydralazine
(80 mg/liter; Apresolinei, Ciba) and chlorothiazide (1000 mgi'
liter; Diuril®, Merck, Sharp & Dohme) added to the drinking
water of both strains of animals at 5, 10, 20, 30, and 45 weeks ol'
age. In addition to the treated SHR and WKY at each period,
untreated SHR and WKY were also monitored.
Operative procedures. The micropuncture procedure fol-
lowed the standard usage of this laboratory [9]. A venous
infusion of isotonic saline solution with synthetic inulin (4 g/dl
of Laevosan) was maintained at a rate of 0.05 mI/mm for the
determination of GFR and tubular fluid-to-plasma inulin con-
centration ([TF/PJ1).
At the start of each clearance period, a bladder catheter was
led into a weighed test tube for urine collection, and tail-vein
blood was collected into heparinized capillary tubes.
Collection micropipettes (tip diameter, 8 to 10 j.), filled just
before use with castor oil dyed with Sudan Black B, were
positioned over the kidney surface with a micromanipulator
(Leitz). Proximal tubular collections of 20 to 50 nl were made
under free-flow conditions over 5- to 12-mm periods. A drop of
oil expelled from the collection pipette indicated the direction of
flow. Each hour, blood and bladder urine samples were collect-
ed,
Analytical methods. Urinary and plasma inulin were ana-
lyzed by the Anthrone method of Fuhr, Kaczmarczyk, and
Kruttgen [10]; tubule fluid inulin, by a micro modification of the
same method [11]; color development in the micro sample, by a
spectrophotometer (Gilford) adapted for a 3-Ill cuvette.
Total protein concentration in overnight urine was deter-
mined by the method of Lowry et a! [12] after trichloroacetic
acid precipitation. Total plasma protein was determined by a
Biuret method [13]; and albumin concentration, by electropho-
retic analysis (see following). Urine and plasma creatinine were
analyzed after adsorption to and elution from Lloyd's reagent
[14].
Analysis of protein in proximal tubular fluid was done by our
modification [15] of Oken's technique for capillary-contained
polyacrylamide gel electrophoresis [16]. Sensitivity of the meth-
od is such as to detect 10_to g of albumin in the sample.
Complete descriptions of the method have been published [15,
16]. Tubular fluid samples were transferred directly from the
collection pipet to an analytical capillary tube within 1 hour of
collection. Sample volume was determined by length ol the
column, as measured by an eyepiece micrometer. Appropriate
standards of diluted rat serum, in volumes comparable to
unknowns, supplied reference curves for each experiment.
A micro-continuous gradient gel electrophoresis procedure
was used for separation and quantitation of proteins in plasma
(diluted 1:51) and urine [7]. The continuous gradient gels were
made in S-p.I microcaps. Solutions of acrylamide, buffer, and
ammonium persulfate were added to the gel in a manner similar
to that used for the discontinuous method. In contrast to the
disc procedure, however, the nonpolymerized acrylamide iii the
microcap was drawn off and replaced by an equivalent amount
of sample or standard. The remaining empty portion of the
microcap was filled with buffer, and electrophoresis was run for
40 mm. The gels were extruded from the capillary tubes, stained
for at least 2 hours, destained overnight, and read in an
ultramicrodensitometer (Joyce-Loebl) with an integrator unit.
Histologic procedures. The heart and kidneys were fixed in
10% phosphate-buffered formalin and embedded in paraffin for
light microscopic studies. Fixed tissues were processed in an
Autotechnicon in graded alcohol solutions and vacuum dried
under 15 pounds of pressure. Sections were cut at thicknesses
of 3 to S ism and stained according to the Armed Forces
Institute of Pathology Manual (1968) with hemotoxylin-eosin,
periodic acid Schiff (PAS), Gomori's aldehyde-fuchsin, Mas-
son's trichrome, silver methanamine, and colloidal iron. The
latter stain was used to assess the integrity of the sialoprotein
layer of the glomerular epithelial cell. The histology of the heart
and kidneys was evaluated by two pathologists independently
and without prior knowledge of the strain and age of the rats.
For immunoflorescence studies, small segments of kidney
were snap frozen in liquid nitrogen and stored at _200 C.
Sections 4-m thick were cut in a cryostat and subsequently
stained with fluorescein-conjugated antisera as described by
Andres et al [17]. Fluorescein-conjugated rabbit antiserum to
rat IgG and goat antiserum to rat C3 were obtained from Cappel
Laboratories (Downingtown, Pennsylvania). They were found
to be monospecific by immunoelectrophoresis, as well as by
immunodiffu sion.
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Table 1. Heart weight in spontaneously hypertensive rat (SHR) and normotensive Wistar-Kyoto controls (WKY)
P P value
Age at death Heart wt/body wt" — — -— Absolute heart wta
N weeks x lO vs. WKY vs. SHR g vs. WKY vs. SHR
21 81—116 5.01 1.02 — < 0.001 1.92 0.35 — < 0.001
6 69—76 6.85 0.99 < 0.001 — 2.87 0.35 < 0.001 —
10 66—70 4.43 1.18 NS < 0.001 1.84 + 0.37 NS < 0.002
15 87—100 5.95 1.23 <0.025 NS 2.19 0.48 NS <0.005
a Mean SD
b Includes all treated animals regardless when treatment started
Treated
Untreated StIR
SHR . 5 30.WKY. 1045ü
20
150
100
50
Survival analysis. An actuarial method was used to assess the
effect of treatment upon survival. Animals taken for functional
or tissue study were censored, whereas all naturally occurring
deaths were uncensored.
Table 2 depicts the median survival times for treated and
untreated SHR and WKY rats. Treated (all drug regimens)
SHR's lived significantly longer than untreated SHR's did (97.6
VS. 66.7 weeks), regardless of the time drug therapy was
started. Cumulative mortality rate (not shown) for untreated
SHR's was 100% by the 75th week, whereas at that time no
treated SHR had died, Table 2 shows that there is no significant
difference between survival times of treated and untreated
WKY's.
Renal junction. Table 3 gives the mean creatinine clearances
(Car) (mllmin x 100 g of body wt) and plasma creatinine
concentrations by group and by age. Measurements were
obtained for each rat at approximately 4- to 12-week intervals
and averaged into three categories by age. A one-way analysis
of variance was used to evaluate the effect of drug treatment on
function, and a test for multiple comparisons was then applied
to compare "no drug" regimens in WKY and SHR to the
various drug regimens in SHR. The results of these statistical
analyses are summarized in Table 3.
Cc,. in WKY was constant throughout the study (Fig. 3a), and
no difference was detectable between treated and untreated
animals. In all age categories, Cr was significantly higher in
WKY than it was in SHR, treated or untreated (Fig. 3, a and b),
and this difference is most marked in the treated SHR's
surviving into the 76- to 100-week age group (Fig. 3a).
Urina,y excretion of protein. Urinary protein excretions for
all groups are plotted against age in Fig. 2a. All show the
expected spurt in total protein excretion (due to low mol wt
proteins) during the period of maturation (3 to 13 weeks). With
this exception, total protein excretion of WKY controls (solid
squares) did not deviate from 6.08 (SD) 1.75 mg124 hr x 100 g
of body wt during the 100 weeks of the study. Untreated SHR's
(open squares) show a steady rise in protein excretion from the
30th week, reaching values nearly five times that of the control
(28.9 11.8 mg/24 hr x 100 g of body wt) shortly before death.
Treated SHR groups show a fairly constant protein excretion
rate of 10.0 (SD) 2.2 mg/24 hr x 100 g of body wt, tip to 50
weeks of age (shaded area in Fig. 2a). Thereafter, despite
nornal arterial pressures, protein excretion rises steadily to
double its value at 80 weeks, and then ftillows a rapidly
accelerating course to reach 4, 6, and 8 times its original value
at 100 weeks (Fig. 2a).
0 10 20 30 40 50 60
-
70 80 90 100
Age, weeks
Fig 1. Blood pressure ps. age. The systolic blood pressure is deter-
mined by an indirect method without anesthesia. The vertical T-bars
denote I so.
Values are given as the means SD. Student's t test was used
for statistical analysis.
Results
Heartweights. Ratiosof heart weight/body weight for treated
and untreated SHR's are given along with those for WKY
normotensive controls at comparable ages in Table 1. The six
untreated SHR's died between the 69th and 75th week; their
heart weight ratios are significantly larger than treated SHR's of
the same age (P < 0.001). Despite a lifetime of lower than
normal blood pressure, SHR's treated for 87 to 100 weeks had
significantly larger heart/body weight ratios than did WKY's
matched for age (P < 0.025).
Blood pressure response to therapy. In Fig. 1, the open
squares trace the course of systolic pressure in the untreated
SHR's, the closed squares that of WKY, normotensive con-
trols. Systolic blood pressures were not significantly different
whether measured directly or indirectly, with or without anes-
thesia [7]. Vertical lines dropped from the SHR curve mark the
initiation of antihypertensive treatment at intervals from 5 to 45
weeks. Note that, regardless of the time that treatment is
started, blood pressure drops from hypertensive to normoten-
sive levels on the second day of drug therapy (Fig. 1). Also note
that pressures of treated SHR's are invariably below WKY
normotensive controls.
WKY
Untreated (N 10)
Treated (N = 32)
SHR
Untreated (N = 26)
Treated (N 40)
Lee-Desu statistic is 0.147. df = I.
" Lee-Desu statistic is 35.3, df = 1.
Creatinine clearance, mi/mm x 100 g bod' ut
WKY (37)
SHR (16)
Treated SHR
for 5 weeks (8)
for 10 weeks (8)
for 20 weeks (8)
for 30 weeks (8)
for 45 weeks (8)
Plasma creatinine, mg/dl
WKY (37)
SHR (16)
Treated SHR
for 5 weeks (8)
for 10 weeks (8)
for 20 weeks (8)
for 30 weeks (8)
for 45 weeks (8)
Creatinine clearance
Overall drug effect"
WKY (no drug + all regimens)" vs.SHR (all c/rug regimci,.i)
SHR (no drug)" vs. SHR (all drug regimens)
Plasma creatinine
Overall drug effect'
WKY (no drug + all regimens)" i's .SHR (all c/rug regilneni)
SHR (no drug)" vs .SIIR (all drug regimens)
Median survival time
Censored necks
0.51 Oil" 16]
0.59 0.06' [5]
0.54 0.08' [51
0.53 0.09" [21
Values are means SD. No. of rats are shosn in parentheses: and no. of clearance periods, in brackets. All SHR groups are compared with
WKY to obtain P values.
"P < 0.05.
cp <0.01.
dF statistic P value (with df in parentheses).
P value by Scheffe's test.
Excretion rates for urinary albumin are plotted against age in
Fig. 2b. The striking difference between untreated SHR's (open
squares) and WKY's (solid squares) is again noted. Albumin
excretion in the treated groups begins to rise between the 30th
and 40th week and follows the accelerated course of total
protein excretion (Fig. 2. a and h).
The fractional composition of urinary proteins determined
from their electrophoretic patterns is shown in Fig. 3. The
fraction of albumin fails in the early weeks in all groups
contemporary with the increase in low molecular weight protein
excretion during maturation. Thereafter, the albumin fraction of
total urinary protein rises in all groups, most rapidly in untreat-
ed SHR's, where it reaches 55% shortly before death (72
weeks). The parallel rise in the fraction of albumin after the 30th
week in the treated SHR is notable. After 50 weeks, the values
of treated and untreated SHRs are indistinguishable. The frac-
tion of low mol wt protein falls following maturation in all
groups. The parallelism between treated and untreated SHR's is
again noted.
Tubular fluid protein. Albumin concentration in proximal
tubule fluid samples (TFAIh) taken at random from surface
nephrons of SHR's is not distinguishable from that of WKYs
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Table 2. Median survival time for spontaneously hypertensive rats (Si-LR) and normotensive Wistar-Kyoto controls (WKY) by drug treatment
Uncensored
26
23
14
S
6
26
102.6
89.2
66.7
97.6
P
NS"
< 0.0001"
Table 3. Clearance and plasma concentration of crca(inine normotensive Wistar-Kyoto controls (WKY) and spontaneously hypertensive rats
(SI-IR) at different ages'
At 5 to 40 weeks At 41 to 75 weeks At 76 to 100 weeks
0.69 0.13 [26]
0.56 0.11" [6]
0.62 0.12 1181
0.36
0.4!
0.36
0.52
0.47
0.69 0.12 [28]
0.55 0.09' [6]
0.50 0.04' [5]
0.63 0.08 [3]
0.52 0.09" [4]
0.45 0.05' [5]
0.50 0.10' 41
0.42 0.08 [281
0.52 0.06" [61
0.52 0.05' [51
0.45 0.04 [4]
0.54 0.09" [41
0.57 0.09' [51
0.54 Oil" [5]
0.08' [3]
0.08' [3]
0.03" [3]
0.09 [2]
0.07" [2]
0.38 (1.06 126]
0.41 0.05 [61
0.48 0.13 [6]
0.43 0.06' 15)
0.46 -" 0.07" IS]
().47 0.07" 12]
One—nay A NO VA cold multiple compari,con,c
0.42 0.08 [18]
0.63
0.57
0.68
0.55
0.51
0.08' [3]
0.07' [3]
0.00" [2]
0.10 [2]
0.06 12]
0.004 (4,39) 0.00/ (4,43) 0.01/4 (5,25)
(1.0/ 0.00/ 0.003
NS A/S
0.0/79 (4.39) 0.00/ (5,45) 0.001 (5,24)
0.04 0.003 0.006
A/S NS
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Fig. 2. Protein excretion vs. age: a total protein b albumin. The shaded
area represents + I and — I SD of the mean of all treated SHR groups at
each time period. The vertical T-bars denote one so.
through the 68th week of age (Table 4). At the end of their life-
span (75 weeks), untreated SHR's have significantly higher
levels of TFAIb. Treated SI-fR's show significantly larger values
for TFAIb by the 80th week, and this trend appears to continue,
although later values contain considerable scatter (Table 4).
TFAIb concentration of WKY's are significantly higher by the
2nd year of life, but do not exhibit the extreme values of treated
SHR's.
Average proximal (TF/P) ratios, a measure of proximal
tubular fluid reabsorption, did not change with age or treatment
in SHR's and were not significantly different from the values of
WKY's. The mean value for all groups was 2.07 (SD) 0.21.
Light microscopy. No morphologic damage was apparent in
glomeruli or heart and kidney vessels of' WKY normotensive
controls at any age (Fig. 4). In contrast, all untreated SHR's
showed slight to severe pathology in all categories listed in
Table 5. Damage was most severe in the juxtamedullary zone
and consisted of fibrinoid necrosis, sclerosis, and pericapsular
fibrosis of glomeruli. A decreased affinity for colloidal iron was
apparent in deeper than in superficial glomeruli. Small arteries
exhibited intimal proliferation, hyperplasia of medial muscle
layers, and destruction of internal elastic lamellae.
Fig. 3. Fractional composition of urinary protein at various ages: a
albu,nin b low molecular weight proteins c high mao/ecu/ar weight
proteins. The shaded area represents + I and — I so of the mean of all
treated SHR groups at each time period. The vertical T-hars denote one
so.
Especially notable was the progression and character of
injury in treated SHR's, regardless of the age at which treat-
ment was begun (Table 5 and Fig. 4). These followed exactly,
but somewhat later and to a lesser degree, the pathologic
changes found in their untreated counterparts. Again, lesions
were at first confined tojuxtamedullary zones, sparing the outer
cortex. A much larger percentage (90%) of' SHR's treated for
A Treated
Untreated SHA
SHA 5.30.
WKY • lOa 450
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the longest period had glomeruli showing decreased affinity for
colloidal iron stain.
I,nmunofluorescence. Two untreated SHR and five treated
SHR sacrificed at 73 to 75 and 93 to 100 weeks, respectively,
were studied by the direct immunofluorescence technique. The
glomerular and vascular structures did not contain rat IgG or rail
C3. IgG was identified in tubular casts.
Small arteries in hearts of untreated SHR's invariably re
vealed marked medial hyperplasia, whereas in the hearts of
treated animals this was exceedingly rare, and then of moderate
severity.
Discussion
It is apparent that effective antihypertensive treatment of the
SHR throughout its lifetime prevents neither the renal lesions
characteristic of hypertensive nephropathy nor the pattern of
proteinuria previously defined for the untreated hypertensive
state [7]. On the contrary, both indices of glomerular damage
develop progressively during the 2nd year of life in the contin-
ued absence of hypertension. The late appearance of vascular
injury in these normotensive SHR's accounts for the negative
findings of Freis et al [8], whose studies were terminated after 1
year of observation.
The rapid response of the blood pressure to antihypertensive
agents begun at any age from 5 to 45 weeks is demonstrated in
Fig. I. There is no evidence of a delayed response as treatment
was begun at later times. Any "structural changes in the
resistance vessels" [18] occurring as a result of hypertension
and associated with increased peripheral resistance, therefore
do not lead to refractoriness of response [19, 20].
Cardiac hypertrophy has been documented repeatedly in the
untreated SHR [7, 8,21,22]. Although cardiac hypertrophy was
present as early as 30 weeks of age in untreated SHR's reported
previously [7], treated animals in the present study showed
normal heart weight/body weight ratios as late as the 70th week
(Table 1). This confirms the statement of Freis et al[8] that they
had been able to prevent left ventricular hypertrophy in SHR's
treated during the 1st year of life and examined at 52 weeks. At
100 weeks, despite continuous control of arterial pressure at
lower than normal values, these ratios were significantly larger
in treated SHR's than they were in WKY normotensive con-
trols matched for age (Table I).
It is interesting that Sen et al [23] reported significantly larger
ventricular weights in hydralazine-treated than in methyldopa-
treated SHR's, although arterial pressure was lower in the
hyralazine-treated group. They concluded, as did Tamanek
from similar studies [24], than an elevated blood pressure is not
the only factor contributing to cardiac hypertrophy in these
experimental animals. The present study supports this conclu-
sion.
Survival statistics for all experimental groups (Table 2) bear
out the earlier studies of Freis et al [8], Freis and Ragan 121],
and Folkow [19]. Effective control of blood pressure unequivo-
cally prolongs the life span of the SHR, The mean survival time
of untreated SHR's, followed by Freis and Ragan [21], was 73
weeks, in close agreement to the value (66.7 weeks; Table 2)
reported here. On the other hand, 50% of treated animals were
living at 100 weeks when the present study was terminated.
With continued treatment, 22% of Freis and Ragan's animals
Table 4. Tubular fluid albumin concentration and tubular fluid-to-
plasma inulin concentration in Wistar-Kyoto rats (WKY) and
spontaneously hypertensive rats (SHR)
Age TFAII,h
Group weeks mg/c/I (TF!P)1"
WKY 67 to 68 2.4 1.1 2.2 0.5
(4) (18) (15)
93 to 116 5.8 2.0' 2.3 0.8
(5) (10) (Ii)
SHR 67 to 68
(3)
73 to 75
(3)
1.7 1.3
(17)
7.2 5.8c
(24)
1.9 :t 0.5
(22)
2.4 0.9
(11)
Treated SHR
drugs at 5 to 10 weeks 103 to 104
(3)
11.1 12.lc
(23)
2.4 1.0()
drugs at 20 weeks 93 to 97
(3)
15.6 13.4c
(19)
drugs at 30 to 45 weeks 82 to 83
(3)
97
(3)
4.8 3.4'
(31)
4.8 6.7'
(25)
1.9 0.5
(26)
2.1 :t 0.6
(17)
Numbers in parentheses denote number of animals (under age
heading) or number of tubule fluid samples.
Average values were used for the proximal convoluted tubule.
Significantly different (P < 0.05) from SHR at 67 to 68 weeks.
lived to 120 weeks, and 11% to 152 weeks [211, the normal life
span of the albino rat [25].
Reduction in renal function, as evidenced by declining creati-
nine clearance and rising serum creatinine concentration (Table
3), is consistent with the severity of morphologic damage found
at autopsy (Table 5, Fig. 4a). It is of interest that treatment
normalizing arterial pressure did not make a distinctive differ-
ence to renal function of SHRs surviving into the 2nd year
(Table 3). Of perhaps more significance is the finding (Table 5)
that early treatment afforded no greater protection against renal
injury than treatment begun at the 30th or 45th week of li[e.
Total urinary protein excretion in untreated SHR and V/KY
(Fig. 2a) confirms and extends our earlier report, in which these
strains were followed to the 65th week of life [71. The age-
related proteinuria. described in other strains of rat [261 is not
found in these normotensive WKY's, whose urinary protein
excretion is nearly constant throughout the 100 weeks of
observation (Fig. 2a). In marked contrast are the values of
urinary protein excretion in treated normotensive SHR's (Fig.
2a). Despite normal arterial pressure, total urinary protein rises
steadily after the 50th week, and at a sharply increasing rate
after week 75. A reduction in the excretion of low mol wt
proteins with an increase in that of albumin and globulin is seen
terminally in Fig. 3, a—c. This diminishing selectivity in the
filtration barrier for plasma proteins reflects the accelerated
renal injury during the final weeks in both treated and untreated
SHR's (Table 4).
Tubular fluid albumin concentrations of WKY (2.4 1 mg/dl)
and untreated SHR (1.7 1.3 mg/dl) (Table 4) are in good
agreement with corresponding values (2.6 0.9 and 2.1 i: 1.8
mg/dl, respectively) found in the two strains from 6 to 65 weeks
in our previous study [7]. Over the same 60-week period, we
noted a fourfold increase in urinary albumin excretion, which,
in the presence of an unchanging TFAIh concentration in surface
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Fig. 4. a Light micrograph f the inner cortex and outer medulla oft/ic kidney of an SHR at 103 weeks of age. Antihypertensive treatment was start-
ed at 10 weeks. Most glomeruli are affected by a process of sclerosis. Bowman's space of several glomeruli is widened. Many proteinaceous casts
are present in dilated tubular lumina. Areas of tubular atrophy are also noted. (PAS; x80) bLight micrograph of the inner cortex and outer medulla
of the kidney of a WKY rat at 103 weeks of age. Administration of antihypertensive drugs was started at 5 weeks. All renal structures appear
normal. (PAS; x80)
' .. r'.t. ' -.
-1
Decreased
Glomeruli Tubular casts Vessels affinity for
No. of colloidal iron
rats 0 + ++ +++ 0 + ++ +++ 0 + ++ +++ stain, no. of rats
66—70 II 6 5 0 0 0 9 2 0 6 4 1 0 2
87—100 10 1 2 7 0 0 I 7 2 2 8 0 0 9
Untreated SHR 69—75 8 0 2 5 1 0 4 3 1 0 3 4 1 5
The lesions were arbitrarily graded as follows: 0, absent; +, slight; ++, moderate: +++, severe. The glomeruli and vessels of the kidneys of
control WKY rats (3 untreated and 15 treated) appeared normal. In 3 WKY rats, a few tubular casts (+) were present in the cortex.
tubules, led us to propose an important role for juxtamedullary
glomeruli in the protein excretion of early hypertensive
nephropathy in SHR. This assumption seemed to be born out in
the pathologic findings that appeared earliest and evolved most
rapidly injuxtamedullary glomeruli [7]. That the inner cortex is
the preferred site for initial renal injury in SHR has been
confirmed recently in a brief report by Saito and Mukaino [271.
The importance of inner cortical glomeruli as the initial source
of protein loss is further supported by data in Table 4, in which
proximal tubule fluid albumin concentrations spanning the
period of the present study are recorded. Note Table 4 that
albumin concentrations of fluid from surface tubules have not
increased in SHR at 67 to 68 weeks compared with WKY,
although Fig. 2a shows that urinary protein excretion has
increased eightfold. By week 75, some rise in tubule fluid
albumin is found, indicating involvement of superficial neph-
rons. Treated SHR show comparable or even greater tubule
fluid albumin levels at later ages.
A strong negative charge on the glomerular membrane is now
recognized as an important barrier to the filtration of negatively
charged protein molecules [28—301. Loss or reduction in this
charge is associated with increased filtration of albumin in a
number of glomerulopathies [31—36]. The decreased affinity for
colloidal iron seen in inner, compared to outer, cortical glomer-
uli in the present study, documents a loss of negative charge
and supports the morphologic and indirect micropuncture evi-
dence that deeper glomeruli are responsible for the major
urinary protein loss in treated and untreated SHR's. It is again
noted that treatment delays, but does not prevent, the patholog-
ic change. At 87 to 100 weeks, inner cortical glomeruli of
treated SHR's demonstrate a decrease in colloidal iron staining,
comparable to untreated SHR's at 69 to 75 weeks (Table 5).
The progression of renal vascular lesions and proteinuria in
the normotensive SHR and the failure of either to evolve in
WKY controls point to a genetic difference in the vascular
system of the SHR, a difference that regularly accompanies the
hypertensive trait. Striking functional differences in smooth
muscle of SHR compared with that of normotensive WKY are
now known to precede the structural correlates we have
described, and these also are clearly not related to the effects of
increased vascular pressure. Greenberg and Bohr 1371 and
Greenberg [381 demonstrated enhanced contractility of portal
veins of SHR versus WKY, and Greenberg, Palmer, and
Wilborn [39] have shown that pressure-independent" hyper-
trophy occurs in smooth muscle of portal veins, vena cavae,
and pulmonary arteries of the spontaneously hypertensive
strain.
At the cellular level, Jones [40] has observed altered ion
transport by vascular smooth muscle cells of SHR compared
with WKY, a decreased ability to accumulate potassium and
extrude sodium; and Postnov et al [41, 42] have described
similar findings in the red cell membrane of SHR. In both
studies, the change in permeability characteristic was attributed
to a lesser ability of the SHR membrane to bind calcium. The
altered ionic distribution in the red cell was first described in
association with human essential hypertension [43] and is the
basis of a recently proposed laboratory test for essential li yper-
tension in man [441. That this phenomenon may be part of a
widespread inherited membrane defect has been suggested by
Postnov, Orlov, and Pokudin [45].
We have described a progression of glomerular injury that
appears to be an expression of difference in genotype between
the spontaneously hypertensive rat and its normotensive Wis-
tar-Kyoto control. The lesion can be recognized after the 30th
week of life in SHR by characteristic morphologic and prDtein-
uric patterns. Hypertension and the propensity to glomerular
injury appear to be genetically associated, occurring together in
the SHR, absent in WKY, and it is fair presumption that both
are somehow related to the membrane defect for which evi-
dence has been cited above. The morphologic and or biochemi-
cal faults that predispose to arteriolar sclerosis may underlie the
early and persistent vasospasm documented in the SHR [46,
47]. In vascular smooth muscle, permeability changes to sodi-
um, potassium, and calcium ions have been suggested as the
basis of alterations in vascular tone and peripheral resistance
[40, 48].
Pharmacologic control of hypertension in the SHR has un-
masked a special vulnerability of its vascular system. The early
functional expressions of this must now be examined for their
role in the pathogenesis of hypertension.
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